RhumbLine Advisers’s Accretive Health AH Stock Holding History

RhumbLine Advisers’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-31,480	Closed	-$252K	–	3165
2014 Q1	$252K	Sell	31,480 -22,880	-42%	-$203K	﹤0.01%	2641
2013 Q4	$498K	Sell	54,360 -1,000	-2%	-$8.61K	﹤0.01%	2260
2013 Q3	$505K	Buy	55,360 +365	+0.7%	+$3.63K	﹤0.01%	2202
2013 Q2	$594K	Buy	+54,995	New	+$579K	﹤0.01%	2132

Other funds holding AH

JRP

Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

RMC

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

BCM

Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return

ECM

EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MIM

Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

SCM

Stonebridge Capital Management Los Angeles, California $208M AUM

RhumbLine Advisers's AH Position: Q2 2014 in Review

RhumbLine Advisers sold out of Accretive Health (AH) in Q2 2014, closing a stake of 31,480 shares — an estimated $252K sold.

RhumbLine Advisers first reported a position in AH in Q2 2013 and held it in 4 quarters. The position peaked at $594K in Q2 2013. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

RhumbLine Advisers reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
RhumbLine Advisers sold 31,480 Accretive Health shares in Q2 2014, an estimated $252K.
RhumbLine Advisers first reported a position in Accretive Health in Q2 2013 and held it in 4 quarters.
RhumbLine Advisers's Accretive Health position peaked at $594K in Q2 2013.
12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.